| 摘要 |
Disclosed is the use of a compound of formula (I) in the manufacture of a medicament for the treatment or prophylaxis of neuropsychiatric disorders in a host in need thereof, or a pharmaceutically acceptable salt, or ester, thereof, wherein the variables are as defined in the specification, and wherein the disorder is depression. The preferred compound of formula (I) is represented by formula (A) shown herein.
|
